Image For Activity Cover
Digital Therapeutics for Substance Use Disorders: Research Priorities and Clinical Validation - On Demand
Course Overview

Presenter: Will M. Aklin, PhD, Director, Behavioral Therapy Development Program, Division of Therapeutics and Medical Consequences (DTMC), NIH, National Institute on Drug Abuse (NIDA)  

Target Audience: This activity is designed for physicians, nurse practitioners or other advanced practice nurses, PAs, and pharmacists. This activity is accredited for physicians, nurse practitioners or other advanced practice nurses, PAs, and pharmacists.

Webinar Description: There are effective treatments for Substance Use Disorders (SUDs), though they do not work for all patients and efficacy decreases over the long-term. As evidenced during the COVID-19 pandemic, traditional methods of delivering treatment have limitations and can be difficult or even impossible to access. Thus, there is an urgent need for new therapeutic options. This webinar will highlight research to support the development of safe and effective Digital Therapeutics (DTx), discuss strategies to accelerate their delivery to patients, and improve SUD treatment outcomes. DTx, a subset of digital health, consists of high-quality software programs to prevent, manage, or treat medical conditions. DTx that meet the definition of a medical device go through an FDA regulatory review process to be legally marketed in the US. The ultimate goal of this webinar is to illuminate NIH-research priorities and clinically validated DTx options for patients with SUDs. 

Educational Objectives:

  • Discern which technologies constitute digital therapeutics
  • Gain an understanding of digital therapeutics as stand-alone treatments or integrated with FDA-approved substance use disorder treatments
  • Learn about the FDA authorization process for digital therapeutics
Certificate Instructions
In order to receive maximum credit, learners must:  

1. Complete the learning material located under "Course Content" 

2: "Start" and complete the "Survey" in reference to this activity.

3: "Start" and complete the final PCSS course "Evaluation" to assess satisfaction and plans for individual and/or team practice change. 

: Follow instructions at the end of the course regarding how to retrieve a certificate. 
Availability: On-Demand
Expires on Oct 19, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 PA-CME Credit
1 Other Professionals Credit
1 Nursing Credit
1 Pharmacy Credit
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

8-Hour DEA Training Inquiries, email PCSS-MOUD.


Powered By